Crystagen
Also known as: Crystagen, EDP, Glu-Asp-Pro
Verified with qualification. Identity mapped to EDP (Glu-Asp-Pro) in a peer-reviewed review; the trade-name-to-material mapping remains pending an exact-lot COA and MS confirmation. Do NOT substitute KED (which the literature associates with Vesugen).
Molecular Overview
Crystagen is a short peptide bioregulator that authoritative literature identifies as the tripeptide Glu-Asp-Pro (EDP). Independent scientific characterization of biological activity remains limited.
Mechanistic Background
A specific, independently characterized mechanism is not well established. Consult primary literature and product documentation.
What Researchers Study
The peptide-bioregulator literature is limited and should be interpreted cautiously.
Evidence Landscape
Current evidence level: LIMITED / EMERGING. Preclinical evidence does not equate to demonstrated human efficacy.
Research Limitations
Identity is verified with qualification at the chemical level; product-level confirmation requires the supplier/exact-lot COA with MS/LC-MS identity and HPLC purity before an inventory lot is marked fully verified.
Scientific References
Research Use Only
Molecularix Biolabs provides research materials for legitimate laboratory research. Information in this Research Library is provided for educational and scientific reference purposes and is not medical advice, treatment guidance, or a recommendation for human or veterinary use.